Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sulfonylurea treatment in young children with neonatal diabetes: dealing with hyperglycemia, hypoglycemia, and sick days.

Diabetes care - 1 May 2007

Codner Ethel, Flanagan Sarah E, Ugarte Francisca, García Hernán, Vidal Teresa, Ellard Sian, Hattersley Andrew T

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Mellitus
Share to Glyburide
Share to Health Status
Share to Hyperglycemia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypoglycemia

Share to Hypoglycemic Agents

Share to Potassium Channels, Inwardly Rectifying

Share to Sulfonylurea Compounds

Source

Open in PubMed Open full text

Identifiers

PMID: 17337505
DOI: 10.2337/dc06-2134
PMCID: PMC7611808

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sulfonylurea treatment in young children with neonatal diabetes: dealing with hyperglycemia, hypoglycemia, and sick days.PMID 17337505Read ↗

Treatment of hyperglycemia in a 7-year-old child diagnosed with neonatal diabetes.Semantic proximity Read ↗

New uses for old drugs: neonatal diabetes and sulphonylureas.Semantic proximity Read ↗

[Permanent neonatal diabetes with known genetic background: oral drugs in treatment of childhood diabetes].Semantic proximity Read ↗

Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations.Semantic proximity Read ↗

Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) geneSemantic proximity Read ↗

[Low doses of sulphonyluria as a successful replacement for insulin therapy in a patient with neonatal diabetes due to a mutation of KCNJ11 gene encoding Kir6.2].Semantic proximity Read ↗

Are sodium-glucose cotransporter-2 inhibitors safe adjunctive drugs during insulin therapy in young children with type 1 diabetes? The first case of type 1 diabetes with SLC5A2 mutation.Semantic proximity Read ↗

[From injections to pills--neonatally diagnosed diabetes of mother and baby].Semantic proximity Read ↗

Imperfect Advice: Neonatal HypoglycemiaSemantic proximity Read ↗

Sufficient increment of sulfonylurea without reintroduction of insulin ameliorates pubertal deterioration of glycaemic control in KCNJ11 neonatal diabetes treated with long-term sulfonylurea.Semantic proximity Read ↗

Neonatal diabetes: the brain comes into focus.Semantic proximity Read ↗

Pharmacologic approaches to the prevention of type 2 diabetes in high risk pediatric patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.